Neuronetics, Inc. — Form 8-K
Filed July 20, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 42/100
What the filing says
Nir Naor appointed CFO effective July 23, 2026, at $480,000 base salary with 500,000 RSU inducement grant (4-year vest). Andrew Macan, EVP/Chief Legal Officer, separates August 15, 2026, receiving $475,087.50 severance over 12 months plus $231,750 retention bonus, 12 months COBRA, and 164,361 RSUs vesting at separation. Cory Anderson promoted to EVP/GM Greenbrook effective July 1, 2026.
Why this rating
Material management reshuffling (CFO replacement, legal officer departure) represents ordinary succession planning. Inducement grant dilutes existing shareholders by ~0.6% (500k shares relative to typical biotech cap table). Severance (~$707k total for Macan) is ~0.5% of company's $129M market value—manageable. No revenue/operational impact disclosed.
See more from July 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.